Cargando…
Generation of “Virtual” Control Groups for Single Arm Prostate Cancer Adjuvant Trials
It is difficult to construct a control group for trials of adjuvant therapy (Rx) of prostate cancer after radical prostatectomy (RP) due to ethical issues and patient acceptance. We utilized 8 curve-fitting models to estimate the time to 60%, 65%, … 95% chance of progression free survival (PFS) base...
Autores principales: | Jia, Zhenyu, Lilly, Michael B., Koziol, James A., Chen, Xin, Xia, Xiao-Qin, Wang, Yipeng, Skarecky, Douglas, Sutton, Manuel, Sawyers, Anne, Ruckle, Herbert, Carpenter, Philip M., Wang-Rodriguez, Jessica, Jiang, Jun, Deng, Mingsen, Pan, Cong, Zhu, Jian-guo, McLaren, Christine E., Gurley, Michael J., Lee, Chung, McClelland, Michael, Ahlering, Thomas, Kattan, Michael W., Mercola, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897405/ https://www.ncbi.nlm.nih.gov/pubmed/24465467 http://dx.doi.org/10.1371/journal.pone.0085010 |
Ejemplares similares
-
Correction: Expression Changes in the Stroma of Prostate Cancer Predict Subsequent Relapse
por: Jia, Zhenyu, et al.
Publicado: (2012) -
Expression Changes in the Stroma of Prostate Cancer Predict Subsequent Relapse
por: Jia, Zhenyu, et al.
Publicado: (2012) -
An Accurate Prostate Cancer Prognosticator Using a Seven-Gene Signature Plus Gleason Score and Taking Cell Type Heterogeneity into Account
por: Chen, Xin, et al.
Publicado: (2012) -
The identification of trans-associations between prostate cancer GWAS SNPs and RNA expression differences in tumor-adjacent stroma
por: Chen, Xin, et al.
Publicado: (2015) -
Six stroma-based RNA markers diagnostic for prostate cancer in European-Americans validated at the RNA and protein levels in patients in China
por: Zhu, Jianguo, et al.
Publicado: (2015)